Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Fluvastatin products are in shortage in Canada (1 of 3 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer. The latest estimate for affected products to return is Aug 31, 2026.
A statin used to lower cholesterol and reduce the risk of heart disease.
Products affected
1 / 3
In shortage since
Jun 3, 2026
Est. full return
Aug 31, 2026
Reports on file
15
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
TEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · since Jun 3, 2026, est. end Aug 31, 2026 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Sep 18, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Apr 24, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Jan 10, 2024 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Jul 4, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Apr 27, 2023 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Dec 14, 2021 · Demand increase for the drug.
Resolved
TEVA-FLUVASTATIN
20MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299224 · ended Apr 28, 2021 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Mar 24, 2021 · Disruption of the manufacture of the drug.
Resolved
TEVA-FLUVASTATIN
40MG · CAPSULE · TEVA CANADA LIMITED
DIN 02299232 · ended Jun 3, 2020 · Disruption of the manufacture of the drug.
DIN 02299224 · ended Apr 1, 2020 · Disruption of the manufacture of the drug.
Showing 12 of 15 reports. All reports are on file with Health Canada.
What's happening
Fluvastatin is currently affected by an active shortage report filed with Health Canada by TEVA CANADA LIMITED.
The reported cause is: disruption of the manufacture of the drug. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Fluvastatin is classified under “LIPID MODIFYING AGENTS, PLAIN” (ATC C10AA).
Recent changes
No changes recorded yet.
Common questions
What is Fluvastatin used for?
A statin used to lower cholesterol and reduce the risk of heart disease.
When will Fluvastatin be back in stock in Canada?
The latest manufacturer estimate is Aug 31, 2026. Estimates are self-reported and often slip; this page updates automatically when they change.
Why is Fluvastatin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.